DIFFICULTIES IN DIAGNOSING PANCREATIC CANCER
https://doi.org/10.21886/2712-8156-2020-1-1-101-105
Abstract
About the Authors
N. V. PorodenkoRussian Federation
Cand. Sci. (Med.), Associate Professor
Krasnodar
U. G. Zvyaginceva
Russian Federation
Cand. Sci. (Med.), Associate Professor
Krasnodar
V. V. Zapevina
Russian Federation
Cand. Sci. (Med.), Associate Professor
Krasnodar
D. V. Sirotenko
Russian Federation
Cand. Sci. (Med.)
Krasnodar
M. N. Kuznecova
Russian Federation
Cand. Sci. (Med.)
Krasnodar
A. A. Korotkih
Russian Federation
Krasnodar
References
1. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview.Nat Rev Gastroenterol Hepatol. 2009;6(12):699-708. DOI:10.1038/nrgastro.2009.177.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians. 2015;65(2):87-108. DOI: 10.3322/caac.21262.
3. Nagriala AM, China VT, Sjoquistc KM, Pajic M, Horvath LG, Biankin AV, et al. Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials. Critical Reviews in Oncology/Hematology. 2015;96(3):483-497. DOI:10.1016/j.critrevonc.2015.07.007.
4. Huang Y, Cai X, Qiu M, Chen P, Tang H, Hu Y, et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia. 2014;57(11):2261-9. DOI: 10.1007/s00125-014-3361-2.
5. Jurowich C, Meyer W, Fdamus R., Kaiser A. Portae vein resection in the framework of surgical therapy of pancreatic head carcinoma: clarification of indication by improved preoperative diagnostic procedures. Chirurg. 2010;71(7):803-807. DOI:10.1007/s001040051139.
6. Mizumoto R., Hamada N. Carcinoma pancreatic head. Nippon. Yeka Yarkkai Zassi, 2010;101(12):869-876.
7. Wang L Zhao VP, Lee C, Liao Q. Diagnosis and treatment of malignant pancreatic endocrine tumor. Journal of Clinical Medicine. 2004;19(2):130-3. PMID: 15250251
8. Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD., Biankin AV, et al. Pancreatic cancer. Nature Reviews Disease Primers. 2016;2:16022. DOI: 10.1038/nrdp.2016.22.
9. Stepanova Yu.A., Vetsheva N., Karmazanovsky G.G., Kriger A.G., Gorin D.S., Shchegolev A. Radiology diagnostics of solidpseudopapillary pancreatic tumors at the stages of surgical treatment. HPB: The Official Journal of the International Hepato Pancreato Biliary Association. 2014;16(2):276-277. DOI:10.1111/hpb.12231.
10. Hartman DJ., Krasinskas AM. Assessing treatment effect in pancreatic cancer. Arch Pathol Lab Med. 2012;136:100-09. DOI:10.5858/arpa.2011-0144-RA.
11. Dusch N, Weiss C, Strbel P, Kienle P, Post S, Niedergethmann M. Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas: 40 years of experience. J Gastrointest Surg. 2014;18:674-681. DOI: 10.1007/s11605-013-2408-x.
Review
For citations:
Porodenko N.V., Zvyaginceva U.G., Zapevina V.V., Sirotenko D.V., Kuznecova M.N., Korotkih A.A. DIFFICULTIES IN DIAGNOSING PANCREATIC CANCER. South Russian Journal of Therapeutic Practice. 2020;1(1):101-105. (In Russ.) https://doi.org/10.21886/2712-8156-2020-1-1-101-105